Mercado cerrado
Inhibrx Biosciences/INBX
13:30
15:10
16:45
18:25
20:00
1D1S1MAHF1A5Y
Acerca de Inhibrx Biosciences
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Símbolo
INBX
Sector
Cotiza en
Industria
Biotecnología
Sede central
Empleados
169
Página web
Métricas de INBX
BásicoAvanzado
211 M$
Capitalización
0.12
PER
118,83 $
BPA
-
Beta
-
Dividendos
Precio y volumen
Capitalización
211 M$
Solvencia financiera
Ratio de solvencia
6,198
Test ácido
5,845
Ratio de endeudamiento total
0,99
Eficacia de la gestión
Valoración
Ratio precio-beneficio (TTM)
0,123
Ratio precio-ventas (TTM)
124,938
Ratio precio-valor contable
0,99
Ratio precio-valor contable neto (TTM)
0,99
Ratio precio-flujo de caja libre (TTM)
-1,213
Crecimiento
Rendimiento financiero de INBX
Cuenta de resultados
Ingresos y gastos
TrimestralAnual
Q3 24
Crecimiento intertrimestral
Ingresos
37 mil M$
-39,75 %
Beneficios
45 mil M$
107,52 %
Margen de beneficio
37,65 %
6,78 %
Noticias de INBX
TodosArtículosVídeos
![Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights](/_next/image?url=https%3A%2F%2Fcdn.snapi.dev%2Fimages%2Fv1%2Fz%2Ft%2Fpress17-2587594.jpg&w=3840&q=75)
Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
PRNewsWire·hace 3 semanas
![Inhibrx: Continued Advancement Even After INBRX-101 Sale To Sanofi](/_next/image?url=https%3A%2F%2Fcdn.snapi.dev%2Fimages%2Fv1%2Fg%2Fv%2Fbiotech11-2469058.jpg&w=3840&q=75)
Inhibrx: Continued Advancement Even After INBRX-101 Sale To Sanofi
Seeking Alpha·hace 3 meses
![Top 4 Health Care Stocks That Are Preparing To Pump This Month - Inhibrx Biosciences (NASDAQ:INBX)](/_next/image?url=https%3A%2F%2Fcdn.snapi.dev%2Fimages%2Fv1%2Fg%2Fz%2Fhealth-care-cost-illustration-2463394.jpeg&w=3840&q=75)
Top 4 Health Care Stocks That Are Preparing To Pump This Month - Inhibrx Biosciences (NASDAQ:INBX)
Benzinga·hace 3 meses
Los datos expuestos son meramente indicativos y no se garantiza que sean exactos o completos. El precio de ejecución real puede variar. Rentabilidades pasadas no son indicativas de resultados futuros. Tu rentabilidad puede verse afectada por las fluctuaciones monetarias y las comisiones y gastos aplicables. Capital en riesgo.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.